Shenkang injection improves chronic kidney disease by inhibiting multiple renin-angiotensin system genes by blocking the Wnt/β-catenin signalling pathway

• Main Authors: Yan-Ni Wang (Author), Hong-Jiao Liu (Author), Li-Li Ren (Author), Ping Suo (Author), Liang Zou (Author), Ya-Mei Zhang (Author), Xiao-Yong Yu (Author), Ying-Yong Zhao (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Chronic kidney disease (CKD) is a major worldwide public health problem. The increase in the number of patients with CKD and end-stage kidney disease requesting renal dialysis or transplantation will progress to epidemic proportions in the next several decades. Although blocking the renin-angiotensi...